CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Payments of Financing Costs
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Payments of Financing Costs of $0 for the 12-month period ending 2023-12-30, per its 10-K filed 2024-02-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2024-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments of financing costs for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments of financing costs for the quarter ending 2022-09-24 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments of financing costs for the quarter ending 2022-06-25 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments of financing costs for the quarter ending 2022-03-26 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments of financing costs for fiscal 2023 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments of financing costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments of financing costs for fiscal 2021 was $38.26M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments of financing costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2023-12-30 | $0.00 10-K · filed 2024-02-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $0.00 derived: sum of 2 quarters · filed 2024-02-14 | $0.00 derived: sum of 3 quarters · filed 2024-02-14 | $0.00 10-K · filed 2024-02-14 |
| 2022-09-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | $2.00K derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-25 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | $2.00K derived: sum of 3 quarters · filed 2024-02-14 | $89.00K derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-26 | $0.00 10-Q · filed 2022-05-04 | $2.00K derived: sum of 2 quarters · filed 2024-02-14 | $89.00K derived: sum of 3 quarters · filed 2024-02-14 | $9.57M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-25 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $89.00K derived: sum of 2 quarters · filed 2024-02-14 | $9.57M derived: sum of 3 quarters · filed 2024-02-14 | $38.26M 10-K · filed 2024-02-14 |
| 2021-09-25 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $9.57M derived: sum of 2 quarters · filed 2022-11-02 | $38.25M 10-Q · filed 2022-11-02 | $38.25M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-26 | $9.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $38.17M 10-Q · filed 2022-08-03 | $38.17M derived: sum of 3 quarters · filed 2023-02-22 | $38.17M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-27 | $28.68M 10-Q · filed 2022-05-04 | $28.68M derived: sum of 2 quarters · filed 2023-02-22 | $28.68M derived: sum of 3 quarters · filed 2023-02-22 | $28.68M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-26 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 |
| 2020-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | $6.59M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $0.00 10-Q · filed 2021-08-04 | $6.59M derived: sum of 3 quarters · filed 2022-02-16 | $6.59M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-28 | $0.00 10-Q · filed 2021-05-04 | $6.59M derived: sum of 2 quarters · filed 2022-02-16 | $6.59M derived: sum of 3 quarters · filed 2022-02-16 | $6.59M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-28 | $6.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $6.59M derived: sum of 2 quarters · filed 2022-02-16 | $6.59M derived: sum of 3 quarters · filed 2022-02-16 | $6.59M 10-K · filed 2022-02-16 |
| 2019-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $0.00 10-Q · filed 2019-07-31 | $0.00 derived: sum of 3 quarters · filed 2021-02-17 | $23.00K derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-30 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-02-17 | $23.00K derived: sum of 3 quarters · filed 2021-02-17 | $13.40M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $23.00K derived: sum of 2 quarters · filed 2021-02-17 | $13.40M derived: sum of 3 quarters · filed 2021-02-17 | $18.34M 10-K · filed 2021-02-17 |
| 2018-09-29 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $13.40M derived: sum of 2 quarters · filed 2019-11-06 | $18.34M 10-Q · filed 2019-11-06 | $18.34M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-06-30 | $13.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $18.31M 10-Q · filed 2019-07-31 | $18.31M derived: sum of 3 quarters · filed 2020-02-11 | $18.31M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-03-31 | $4.93M 10-Q · filed 2019-05-07 | $4.93M derived: sum of 2 quarters · filed 2020-02-11 | $4.93M derived: sum of 3 quarters · filed 2020-02-11 | $4.93M derived: sum of 4 quarters · filed 2020-02-11 |
| 2017-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $0.00 derived: sum of 2 quarters · filed 2020-02-11 | $0.00 derived: sum of 3 quarters · filed 2020-02-11 | $0.00 10-K · filed 2020-02-11 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |
| 2017-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | ||
| 2017-04-01 | $0.00 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $3.66M 10-K · filed 2019-02-13 | |||
| 2010-12-25 | $14.17M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |